Praxsyn Corporation (PXYN) Financial Statements (2025 and earlier)

Company Profile

Business Address 1803 SKY PARK CIRCLE
IRVINE, CA 92614
State of Incorp. IL
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,8391,8971,222593519820
Cash and cash equivalent4,8391,8971,222593519820
Receivables7,15510,6798,5619,4228,5233,405
Inventory, net of allowances, customer advances and progress billings6402942021057847
Inventory6402942021057847
Other current assets1,0942116262533
Other undisclosed current assets  1,6571,5731,546  
Total current assets:13,72814,54711,57411,6929,1454,305
Noncurrent Assets
Property, plant and equipment1879180564131
Long-term investments and receivables11,5103,7174,1404,4803,1351,381
Accounts and financing receivable, after allowance for credit loss11,5103,7174,1404,4803,1351,381
Regulated entity, other noncurrent assets      6
Other noncurrent assets1488866
Deferred tax assets, net  578903248248248
Other undisclosed noncurrent assets565     
Total noncurrent assets:12,2764,3935,1304,7923,4311,673
TOTAL ASSETS:26,00418,94016,70416,48312,5765,978
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,05911,2009,1112,9211,3213,755
Settlement liabilities23210570100  
Interest and dividends payable1,7001,6571,5731,546  
Taxes payable3,096     
Accounts payable1,726734483453607991
Accrued liabilities1,3068,7046,9848227142,765
Debt3,321(3,678)(3,876)(3,333) 6,331
Disposal group, including discontinued operation932962962962962962
Other liabilities      
Deferred revenue and credits 122122122   
Deferred tax liabilities 339     
Due to related parties97149199199  
Other undisclosed current liabilities7,3387,5548,32815,66313,8542,887
Total current liabilities:20,20616,30814,84516,41316,13713,935
Noncurrent Liabilities
Long-term debt and lease obligation192210227   
Long-term debt, excluding current maturities192210227   
Liabilities, other than long-term debt347377377   
Accounts payable and accrued liabilities347377377   
Other undisclosed noncurrent liabilities(347)(377)(377)   
Total noncurrent liabilities:192210227   
Total liabilities:20,39816,51815,07216,41316,13713,935
Equity
Equity, attributable to parent5,6062,4231,63271(3,561)(7,957)
Treasury stock, value  (200)(200)(200)(200)(200)
Additional paid in capital54,05954,25954,24052,66849,48544,309
Accumulated deficit(48,453)(51,636)(52,408)(52,397)(52,847)(52,066)
Total equity:5,6062,4231,63271(3,561)(7,957)
TOTAL LIABILITIES AND EQUITY:26,00418,94016,70416,48312,5765,978

Income Statement (P&L) ($ in thousands)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
Revenues17,64314,18311,24122,89623,2439,220
Revenue, net(10,074)(6,848)11,24122,89623,2439,219
Cost of revenue(2,019)(1,132)(1,153)(1,126)(975)(332)
Gross profit:15,62413,05210,08821,77022,2688,888
Operating expenses(9,984)(8,081)(5,435)(9,852)(13,679)(7,981)
Operating income:5,6394,9714,65311,9188,589907
Nonoperating income (expense)(90)(3,690)(4,877)(11,468)(9,370)(12,920)
Interest and debt expense(90)(3,690)25,767(10,959)(9,559)(5,808)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes903,690(25,767)10,9599,5595,808
Income (loss) from continuing operations before income taxes:5,5491,281(225)450(781)(12,012)
Income tax expense(2,367)(509)    
Other undisclosed income from continuing operations   214   
Income (loss) from continuing operations:3,182772(11)450(781)(12,012)
Income (loss) before gain (loss) on sale of properties:3,182772(11)450(781)(12,012)
Net income (loss) available to common stockholders, basic:3,182772(11)450(781)(12,012)
Interest on convertible debt  61 82  
Other undisclosed net income available to common stockholders, diluted7315 0  
Net income (loss) available to common stockholders, diluted:3,255848(11)532(781)(12,012)

Comprehensive Income ($ in thousands)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
Net income (loss):3,182772(11)450(781)(12,012)
Comprehensive income (loss), net of tax, attributable to parent:3,182772(11)450(781)(12,012)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: